MX2020010800A - Composiciones fotoprotectoras que contienen compuestos derivados de malassezia y/o análogos quimicos de los mismos. - Google Patents

Composiciones fotoprotectoras que contienen compuestos derivados de malassezia y/o análogos quimicos de los mismos.

Info

Publication number
MX2020010800A
MX2020010800A MX2020010800A MX2020010800A MX2020010800A MX 2020010800 A MX2020010800 A MX 2020010800A MX 2020010800 A MX2020010800 A MX 2020010800A MX 2020010800 A MX2020010800 A MX 2020010800A MX 2020010800 A MX2020010800 A MX 2020010800A
Authority
MX
Mexico
Prior art keywords
compounds
malassezia
hyperpigmentation
compositions
compounds derived
Prior art date
Application number
MX2020010800A
Other languages
English (en)
Spanish (es)
Inventor
Michael Einziger
Ann Marie Simpson
Original Assignee
Michael EINZIGER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael EINZIGER filed Critical Michael EINZIGER
Publication of MX2020010800A publication Critical patent/MX2020010800A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2020010800A 2018-04-12 2019-04-12 Composiciones fotoprotectoras que contienen compuestos derivados de malassezia y/o análogos quimicos de los mismos. MX2020010800A (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862656769P 2018-04-12 2018-04-12
US201862668007P 2018-05-07 2018-05-07
US201862685800P 2018-06-15 2018-06-15
US201862686912P 2018-06-19 2018-06-19
US201862722412P 2018-08-24 2018-08-24
US201862742657P 2018-10-08 2018-10-08
PCT/US2019/027181 WO2019200232A1 (en) 2018-04-12 2019-04-12 Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof

Publications (1)

Publication Number Publication Date
MX2020010800A true MX2020010800A (es) 2021-01-15

Family

ID=66380162

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020010800A MX2020010800A (es) 2018-04-12 2019-04-12 Composiciones fotoprotectoras que contienen compuestos derivados de malassezia y/o análogos quimicos de los mismos.

Country Status (20)

Country Link
US (2) US11220491B2 (https=)
EP (2) EP3774811B1 (https=)
JP (2) JP7454759B2 (https=)
KR (2) KR102866533B1 (https=)
CN (2) CN113015731B (https=)
AU (2) AU2019251579B2 (https=)
BR (1) BR112020020881A2 (https=)
CA (1) CA3096866A1 (https=)
DK (1) DK3774811T3 (https=)
ES (1) ES3015164T3 (https=)
FI (1) FI3774811T3 (https=)
HU (1) HUE070519T2 (https=)
IL (2) IL277940B2 (https=)
MX (1) MX2020010800A (https=)
PH (1) PH12020551677A1 (https=)
PL (1) PL3774811T3 (https=)
PT (1) PT3774811T (https=)
SG (1) SG11202010077TA (https=)
TW (2) TWI843963B (https=)
WO (1) WO2019200232A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3774811T3 (da) 2018-04-12 2025-03-17 Versicolor Tech Llc Fotobeskyttende sammensætninger indeholdende malassezia afledte forbindelser og/eller kemiske analoger deraf
EP3978499A1 (en) * 2018-06-15 2022-04-06 Versicolor Technologies, Llc Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
KR20210071963A (ko) 2018-08-24 2021-06-16 마이클 아인지거 말라세지아-유래 화합물 및/또는 이의 화학적 유사체를 함유하는 광보호 조성물
EA202092467A1 (ru) * 2018-10-08 2021-02-12 Майкл Айнцигер Фотозащитные композиции, содержащие полученные из malassezia соединения и/или их химические аналоги

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317925B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Bis-eterocicli ad attivita' antitumorale e chemosensibilizzante.
TW200716198A (en) * 2005-05-27 2007-05-01 Hayashibara Biochem Lab Agent for external application to the skin
EP2082736A1 (fr) 2008-01-23 2009-07-29 Jean Hilaire Saurat Composition pharmaceutique à usage topique
AU2013381790A1 (en) 2013-03-13 2015-10-22 Alevere Medical Corporation Use of indole compounds for fat reduction and skin and soft tissue tightening
EP2933935A1 (en) * 2014-04-14 2015-10-21 Alcatel Lucent A method of modulating light in a telecommunication network
US9969686B2 (en) * 2014-08-05 2018-05-15 Wisconsin Alumni Research Foundation Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them
KR20160128764A (ko) 2015-04-29 2016-11-08 주식회사 엘지생활건강 피부 개선용 조성물
AU2017229970B2 (en) * 2016-03-10 2021-10-07 Versicolor Technologies, Llc Malassezin and analogs thereof as skin brightening agents
CN106916171B (zh) * 2017-01-11 2019-02-26 华南师范大学 含有吲哚并[3，2-b]咔唑结构单元的压致变色材料及其应用
DK3774811T3 (da) 2018-04-12 2025-03-17 Versicolor Tech Llc Fotobeskyttende sammensætninger indeholdende malassezia afledte forbindelser og/eller kemiske analoger deraf
EP3790880A1 (en) 2018-05-07 2021-03-17 Einziger, Michael Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
EP3978499A1 (en) * 2018-06-15 2022-04-06 Versicolor Technologies, Llc Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
KR20210071963A (ko) * 2018-08-24 2021-06-16 마이클 아인지거 말라세지아-유래 화합물 및/또는 이의 화학적 유사체를 함유하는 광보호 조성물
EA202092467A1 (ru) 2018-10-08 2021-02-12 Майкл Айнцигер Фотозащитные композиции, содержащие полученные из malassezia соединения и/или их химические аналоги

Also Published As

Publication number Publication date
DK3774811T3 (da) 2025-03-17
WO2019200232A1 (en) 2019-10-17
US20220106297A1 (en) 2022-04-07
EP4545147A3 (en) 2025-10-01
AU2019251579B2 (en) 2024-08-29
IL313054A (en) 2024-07-01
AU2019251579A1 (en) 2020-11-12
CN119350217A (zh) 2025-01-24
JP2021521195A (ja) 2021-08-26
CN113015731B (zh) 2024-09-10
US11220491B2 (en) 2022-01-11
TW202432546A (zh) 2024-08-16
EP3774811B1 (en) 2024-12-18
TW201946621A (zh) 2019-12-16
KR102866533B1 (ko) 2025-09-30
SG11202010077TA (en) 2020-11-27
EP4545147A2 (en) 2025-04-30
KR20210075033A (ko) 2021-06-22
CN113015731A (zh) 2021-06-22
ES3015164T3 (en) 2025-04-29
JP2024091635A (ja) 2024-07-05
US12497385B2 (en) 2025-12-16
JP7454759B2 (ja) 2024-03-25
TW202222307A (zh) 2022-06-16
IL277940B2 (en) 2024-11-01
BR112020020881A2 (pt) 2021-04-20
PL3774811T3 (pl) 2025-06-16
HUE070519T2 (hu) 2025-06-28
US20190345140A1 (en) 2019-11-14
CA3096866A1 (en) 2019-10-17
IL277940A (en) 2020-11-30
JP7821824B2 (ja) 2026-02-27
AU2024266874A1 (en) 2025-01-02
FI3774811T3 (fi) 2025-03-21
IL277940B1 (en) 2024-07-01
TWI742359B (zh) 2021-10-11
EP3774811A1 (en) 2021-02-17
PH12020551677A1 (en) 2021-06-28
KR20250148678A (ko) 2025-10-14
PT3774811T (pt) 2025-03-20
TWI843963B (zh) 2024-06-01

Similar Documents

Publication Publication Date Title
MX2020010800A (es) Composiciones fotoprotectoras que contienen compuestos derivados de malassezia y/o análogos quimicos de los mismos.
PH12020551845A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
PH12021550315A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
PY2084899A (es) Derivados de 3-(5-metoxi-1-oxoisoindolin-2-il)piperidin-2,6-diona y usos de los mismos
PH12021550746A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
BR112018068293A2 (pt) malassezina e seus análogos como agentes de clareamento de pele
MX2017016669A (es) Derivados de piperidina 1,4-sustituidos.
BR112017027147A2 (pt) agente estimulante de restauração/crescimento de cabelo
MX2022003140A (es) Composicion para aclarar la piel.
MX2019007482A (es) Uso de agentes quelantes para mejorar la estabilidad de color del resorcinol.
UY27853A1 (es) Difenilazetidinonas sustituidas en grupo acido, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
PY2243958A (es) Derivados de 3–(5–oxi)–1–oxoisoindolin–2–il)piperidina–2,6–diona y sus usos
BR112017010599A2 (pt) análogos de ureia ligada substituída como moduladores sirtuin
CO2023010940A2 (es) Compuestos moduladores de gcn2 y usos de los mismos
MX2021013010A (es) Composiciones y metodos para modular la actividad del complemento.
CO2019014592A2 (es) Neurotoxina botulínica para el tratamiento de trastornos asociados a la hiperactividad de melanocito y/o exceso de melanina
CR20220553A (es) Pirrolopirimidinaminas como inhibidores del sistema del complemento
PH12020552132A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
EA201690591A1 (ru) Композиция для осветления кожи
CL2023002486A1 (es) Compuestos heterocíclicos como inhibidores de delta-5 desaturasa y métodos de uso
ECSP055985A (es) Derivados de ácido 3-metil-2-(3-(2-fenil-oxazol-4-ilmetoxi)-ciclohexanocarbonil-aminobutírico y compuestos relacionados como moduladores de ppar para el tratamiento de diabetes de tipo 2 y aterosclerosis
ES3059300T3 (en) Non-therapeutic use of an orotic acid derivative for inhibiting melanin production and whitening the skin
MX365370B (es) Composición aclaradora de la piel que comprende 4-hexilresorcinol e ilomastat.
CO6670553A2 (es) Derivados de 3 aminolactama aril sustituidas y composiciones farmaceúticas que lo comprenden
MX2024009743A (es) Analogos de tofa, preparaciones para la reduccion del sebo con un contenido de tales analogos y el uso cosmetico y/o terapeutico de tales analogos como principio eficaz para la reduccion o prevencion del sebo